Should I buy Labcorp (LH) stock or is it too late?
⭐ The most reliable of them, either direction: Morgan Stanley — 69% of its targets hit on this sector (830 calls tested). It aims for $338 (+7.8 %), call made on August 1, 2026, maturing on August 1, 2027 (74 d ago).
Firm-by-firm track record on Labcorp
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| JP Morgan | 100 % | +33.3 % | 5 | $360 +15% |
| UBS | 90 % | +22.2 % | 10 | $380 +21% |
| Citigroup | 100 % | +19.4 % | 5 | $300 -4% |
| B of A Securities | 83 % | +17.4 % | 6 | $320 +2% |
| Barclays | 67 % | +17.1 % | 9 | $330 +5% |
| Baird | 86 % | +13.9 % | 14 | $338 +8% |
| Morgan Stanley | 70 % | +9.6 % | 23 | $338 +8% |
| Truist Securities | 82 % | +7.3 % | 11 | $365 +16% |
✅ Reasons to believe
- 75% of analysts rate it a buy (Buy consensus, 8 ratings) — a sign of market conviction.
- Median price target $338, i.e. +8% from the current price ($314).
- The most reliable firm on LH, JP Morgan (100% hit rate, 5 scored calls), targets $360 (call made on August 3, 2026, maturing on August 3, 2027) (+15%) in its most recent call, and $317 (call made on November 7, 2025, maturing on November 7, 2026) (+1%) in the one coming due soonest.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 8 ratings, 2 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on LH
Median target $338 (+8%) · 8 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Labcorp now?
We won't decide for you. The facts: 75% of analysts rate it a buy, median target $338 (+8%), and JP Morgan (most reliable on LH, 100%) targets $360. Weigh that against valuation (P/E ~26). This is not personalized advice.
Is it too late to invest in Labcorp?
Not according to analysts: the median target ($338) is still +8% above the current price ($314) (most reliable on LH: JP Morgan, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Labcorp still worth investing in?
It depends on the gap between the price ($314) and its estimated value: analysts target $338 on median (+8%), with 75% buys (most reliable on LH: JP Morgan, 100%). Cross-check with their real reliability on LH and the cautions above. Information, not advice.
What's the main risk in buying LH?
The consensus is not unanimous: of 8 ratings, 2 are neutral.
→ Go deeper: the full Labcorp profile (consensus, analyst reliability, price target, performance).